These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 18171937)

  • 41. Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission.
    Jennings KA; Loder MK; Sheward WJ; Pei Q; Deacon RM; Benson MA; Olverman HJ; Hastie ND; Harmar AJ; Shen S; Sharp T
    J Neurosci; 2006 Aug; 26(35):8955-64. PubMed ID: 16943551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Developmental alterations in anxiety and cognitive behavior in serotonin transporter mutant mice.
    Sakakibara Y; Kasahara Y; Hall FS; Lesch KP; Murphy DL; Uhl GR; Sora I
    Psychopharmacology (Berl); 2014 Oct; 231(21):4119-33. PubMed ID: 24728652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Opposing alterations in anxiety and species-typical behaviours in serotonin transporter overexpressor and knockout mice.
    Line SJ; Barkus C; Coyle C; Jennings KA; Deacon RM; Lesch KP; Sharp T; Bannerman DM
    Eur Neuropsychopharmacol; 2011 Jan; 21(1):108-16. PubMed ID: 20863670
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A dialogue between the immune system and brain, spoken in the language of serotonin.
    Baganz NL; Blakely RD
    ACS Chem Neurosci; 2013 Jan; 4(1):48-63. PubMed ID: 23336044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Developmental exposure to a serotonin agonist produces subsequent behavioral and neurochemical changes in the adult male prairie vole.
    Martin MM; Liu Y; Wang Z
    Physiol Behav; 2012 Jan; 105(2):529-35. PubMed ID: 21958679
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Postnatal day 2 to 11 constitutes a 5-HT-sensitive period impacting adult mPFC function.
    Rebello TJ; Yu Q; Goodfellow NM; Caffrey Cagliostro MK; Teissier A; Morelli E; Demireva EY; Chemiakine A; Rosoklija GB; Dwork AJ; Lambe EK; Gingrich JA; Ansorge MS
    J Neurosci; 2014 Sep; 34(37):12379-93. PubMed ID: 25209278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder.
    Garbarino VR; Gilman TL; Daws LC; Gould GG
    Pharmacol Res; 2019 Feb; 140():85-99. PubMed ID: 30009933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-linear relationship between 5-HT transporter gene expression and frequency sensitivity of 5-HT signals.
    Jennings KA; Lesch KP; Sharp T; Cragg SJ
    J Neurochem; 2010 Nov; 115(4):965-73. PubMed ID: 20854367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased serotonin levels associated with behavioral disinhibition in tissue plasminogen activator deficient (tPA-/-) mice.
    Pothakos K; Robinson JK; Gravanis I; Marsteller DA; Dewey SL; Tsirka SE
    Brain Res; 2010 Apr; 1326():135-42. PubMed ID: 20156421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Refining the Role of 5-HT in Postnatal Development of Brain Circuits.
    Teissier A; Soiza-Reilly M; Gaspar P
    Front Cell Neurosci; 2017; 11():139. PubMed ID: 28588453
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Perinatal reduction of functional serotonin transporters results in developmental delay.
    Kroeze Y; Dirven B; Janssen S; Kröhnke M; Barte RM; Middelman A; van Bokhoven H; Zhou H; Homberg JR
    Neuropharmacology; 2016 Oct; 109():96-111. PubMed ID: 27208789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Noradrenergic control of cortico-striato-thalamic and mesolimbic cross-structural synchrony.
    Dzirasa K; Phillips HW; Sotnikova TD; Salahpour A; Kumar S; Gainetdinov RR; Caron MG; Nicolelis MA
    J Neurosci; 2010 May; 30(18):6387-97. PubMed ID: 20445065
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased exploratory activity in a mouse model of 15q duplication syndrome; implications for disturbance of serotonin signaling.
    Tamada K; Tomonaga S; Hatanaka F; Nakai N; Takao K; Miyakawa T; Nakatani J; Takumi T
    PLoS One; 2010 Dec; 5(12):e15126. PubMed ID: 21179543
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Linking emotion to the social brain. The role of the serotonin transporter in human social behaviour.
    Lesch KP
    EMBO Rep; 2007 Jul; 8 Spec No(Suppl 1):S24-9. PubMed ID: 17726438
    [No Abstract]   [Full Text] [Related]  

  • 55. Genetic and early environmental influences on the serotonin system: consequences for brain development and risk for psychopathology.
    Booij L; Tremblay RE; Szyf M; Benkelfat C
    J Psychiatry Neurosci; 2015 Jan; 40(1):5-18. PubMed ID: 25285876
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Behavioral consequences of abnormal cortical development: insights into developmental disabilities.
    Berger-Sweeney J; Hohmann CF
    Behav Brain Res; 1997 Jul; 86(2):121-42. PubMed ID: 9134147
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abnormal Serotonin Levels During Perinatal Development Lead to Behavioral Deficits in Adulthood.
    Shah R; Courtiol E; Castellanos FX; Teixeira CM
    Front Behav Neurosci; 2018; 12():114. PubMed ID: 29928194
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 5-HT interaction with other neurotransmitters: An overview.
    De Deurwaerdere P; Di Giovanni G
    Prog Brain Res; 2021; 259():1-5. PubMed ID: 33541674
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulatory Mechanisms Controlling Maturation of Serotonin Neuron Identity and Function.
    Spencer WC; Deneris ES
    Front Cell Neurosci; 2017; 11():215. PubMed ID: 28769770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bad Behavior: Improving Reproducibility in Behavior Testing.
    Andrews AM; Cheng X; Altieri SC; Yang H
    ACS Chem Neurosci; 2018 Aug; 9(8):1904-1906. PubMed ID: 29363939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.